Kiniksa Pharmaceuticals International plc Class A Ordinary Shares (KNSA)
Stock · NASDAQ · Health Care
$78.08as of 8/28/2026
Price chart
Open in TradingViewActive signals
Support level
$45.41
Industry
Biotechnology: Pharmaceutical Preparations
About KNSA
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigationa…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 366
- Website
- www.kiniksa.com/
Fundamentals
- 1-day range
- $77.71$79.81
- Market cap
- $5.73B
- P/E (trailing)
- 75.29
- P/E (forward)
- 48.27
- EPS (trailing)
- $0.98
- Dividend yield
- —
- Beta
- 0.03
- Avg. volume
- 742.8K
52-week range
$33.25$82.94
Next earnings: October 27, 2026 · EPS estimate $0.32
Forecasts
8 analyst ratings
Buy 93%
Hold 7%
Sell 0%
1-year price forecast
High
$108
+38.3%
Median
$98.5
+26.2%
Low
$87
+11.4%
Kiniksa Pharmaceuticals International plc Class A Ordinary Shares Competitors
Chosen by industry and closest market cap.
- KNSAKiniksa Pharmaceuticals International plc Class A Ordinary Shares$78.1▼ 2.13%Market cap $5.73BP/E 75.29$33.25$82.94
- PTCTPTC Therapeutics Inc. Common Stock$70.01▼ 2.51%Market cap $5.68BP/E —$48.86$90.87
- DNTHDianthus Therapeutics Inc. Common Stock$105.72▼ 5.22%Market cap $5.80BP/E —$22.81$117.88
- LGNDLigand Pharmaceuticals Incorporated Common Stock$280▼ 1.59%Market cap $5.85BP/E 38.07$158.4$326.63
- GRFSGrifols S.A. American Depositary Shares$7.68▼ 1.79%Market cap $5.40BP/E 13.31$8.43$12.87
- BLTEBelite Bio Inc American Depositary Shares$151.65▼ 3.42%Market cap $6.09BP/E —$62.18$200
- ERASErasca Inc. Common Stock$18.03▼ 7.49%Market cap $6.11BP/E —$1.33$24.28
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| KNSA Kiniksa Pharmaceuticals International plc Class A Ordinary Shares | $5.73B | 75.29 | $78.1 | ▼ 2.13% | $33.25$82.94 |
| PTCT PTC Therapeutics Inc. Common Stock | $5.68B | — | $70.01 | ▼ 2.51% | $48.86$90.87 |
| DNTH Dianthus Therapeutics Inc. Common Stock | $5.80B | — | $105.72 | ▼ 5.22% | $22.81$117.88 |
| LGND Ligand Pharmaceuticals Incorporated Common Stock | $5.85B | 38.07 | $280 | ▼ 1.59% | $158.4$326.63 |
| GRFS Grifols S.A. American Depositary Shares | $5.40B | 13.31 | $7.68 | ▼ 1.79% | $8.43$12.87 |
| BLTE Belite Bio Inc American Depositary Shares | $6.09B | — | $151.65 | ▼ 3.42% | $62.18$200 |
| ERAS Erasca Inc. Common Stock | $6.11B | — | $18.03 | ▼ 7.49% | $1.33$24.28 |
P/E shows — for peers not currently carrying a live signal of their own.
See the full, filterable feed with live charts on the MarketWall dashboard.